Inhibition of nitric oxide synthase reduces ultrasonic vocalizations of rat pups

European Journal of Pharmacology

Volumn 382, Issue 3, 1999, Pages 143-150

  Podhorna, Jana ^a   Brown, Richard E ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Anxiety; Locomotion; Nitric oxide (NO); Rat pup; Ultrasonic vocalization

Indexed keywords

7 NITROINDAZOLE; ARGININE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; LOCOMOTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; ULTRASOUND; VOCALIZATION;

ANIMALS; ANIMALS, NEWBORN; ANTI-ANXIETY AGENTS; ARGININE; BODY TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INDAZOLES; MOTOR ACTIVITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, LONG-EVANS; STEREOISOMERISM; ULTRASONICS; VOCALIZATION, ANIMAL;

EID: 0032711909     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00595-6     Document Type: Article

References (52)

1. Ali S.F., Itzhak Y. Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice. Ann. N.Y. Acad. Sci. 844:1998;122-130.
2. Barr G.A., Wang S., Carden S. Aversive properties of the kappa opioid agonist U50,488 in the week-old rat pup. Psychopharmacology. 113:1994;422-428.
3. Bennett D.A., Amrick C.L. 2-Amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepam. Life Sci. 39:1986;2455-2461.
4. Buisson A., Lakhmeche N., Verrecchia C., Plotkine M., Boulu R.G. Nitric oxide: an endogenous anticonvulsant substance. NeuroReport. 4:1993;444-446.
5. Buisson A., Margaill I., Callebert J., Plotkine M., Boulu R.G. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. J. Neurochem. 61:1993;690-696.
6. Campbell J.O., Fogarty J.A., Patia Spear L. Inhibition of nitric oxide synthesis with L-NAME suppresses isolation-induced ultrasounds in rat pups. Pharmacol. Biochem. Behav. 63:1999;45-53.
7. Cespuglio R., Burlet S., Faradji Prevautel H. 5-Hydroxyindoles compounds and nitric oxide voltammetric detection in the rat brain: changes occurring throughout the sleep-wake cycle. J. Neural Transm. 105:1998;205-215.
8. Corbett R., Dunn R.W. Effects of 5,7-dichlorokynurenic acid on conflict, social interaction and plus maze behaviors. Neuropharmacology. 32:1993;461-466.
9. Crosby G., Marota J.J., Huang P.L. Intact nociception-induced neuroplasticity in transgenic mice deficient in neuronal nitric oxide synthase. Neuroscience. 69:1995;1013-1017.
10. Dastur F.N., McGregor I.S., Brown R.E. Dopaminergic modulation of rat pup ultrasonic vocalizations. Eur. J. Pharmacol. 1999;. (in press).
11. Demas G.E., Eliasson M.J., Dawson T.M., Dawson V.L., Kriegsfeld L.J., Nelson R.J., Snyder S.H. Inhibition of neuronal nitric oxide synthase increases aggressive behavior in mice. Mol. Med. 3:1997;610-616.
12. De Oliveira C.L., Del Bel E.A., Guimaraes F.S. Effects of L-NOARG on plus-maze performance in rats. Pharmacol. Biochem. Behav. 56:1997;55-59.
13. Dunn R.W., Corbett R., Martin L.L., Payack J.F., Laws-Ricker L., Wilmot C.A.X., Rush D.K., Cornfeldt M.L., Fielding S. Preclinical anxiolytic profiles of 7189 and 8319, novel non-competitive NMDA antagonists. Prog. Clin. Biol. Res. 361:1990;495-512.
14. Dzoljic E., De Vries R., Dzoljic M.R. Anticonvulsant activity of new and potent inhibitors of nitric oxide synthase. Brain Res. Bull. 43:1997;191-195.
15. Faria M.S., Muscara M.N., Moreno H. Jr., Teixeira S.A., Dias H.B., De Oliveira B., Graeff F.G., De Nucci G. Acute inhibition of nitric oxide synthesis induces anxiolysis in the plus maze test. Eur. J. Pharmacol. 323:1997;37-43.
16. Fraser C.M., Cooke M.J., Fisher A., Thompson I.D., Stone T.W. Interactions between ifenprodil and dizocilpine on mouse behavior in models of anxiety and working memory. Eur. Neuropsychopharmacol. 6:1996;311-316.
17. Gardner C.R. Distress vocalization in rat pups. A simple screening method for anxiolytic drugs. J. Pharmacol. Methods. 14:1985;181-187.
18. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14:1991;60-67.
19. Garthwaite J. Neural nitric oxide signalling. Trends Neurosci. 18:1995;51-52.
20. Glantz S.A. Primer of Biostatistics. 3rd edn. 1992;McGraw-Hill, New York.
21. Guimaraes F.S., Carobrez A.P., De Aguiar J.C., Graeff F.G. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology. 103:1991;91-94.
22. Guimaraes F.S., De Aguiar J.C., Del Bel E.A., Ballejo G. Anxiolytic effect of nitric oxide synthase inhibitors microinjected into the dorsal central grey. NeuroReport. 5:1994;1929-1932.
23. Harrison G.E., Holman S.D. A device to enable the automatic recording of rodent ultrasonic vocalizations. Behav. Res. Meth. Instrum. 10:1978;689-692.
24. Iga Y., Yoshioka M., Togashi H., Saito H. Inhibitory action of N-mega-nitro-L-arginine methyl ester on in vivo long-term potentiation in the rat dentate gyrus. Eur. J. Pharmacol. 238:1993;395-398.
25. Kandasamy S.B. Role of nitric oxide synthase, superoxide dismutase, and glutathione peroxidase in radiation-induced decrease in norepinephrine release. Ann. N.Y. Acad. Sci. 738:1994;163-172.
26. Kato K., Zorumski C.F. Nitric oxide inhibitors facilitate the induction of hippocampal long-term potentiation by modulating NMDA responses. J. Neurophysiol. 70:1993;1260-1263.
27. Klint T., Andersson G. Ultrasound vocalization is not related to corticosterone response in isolated rat pups. Pharmacol. Biochem. Behav. 47:1994;947-950.
28. Krukoff T.L., Khalili P. Stress-induced activation of nitric oxide-producing neurons in the rat brain. J. Comp. Neurol. 377:1997;509-519.
29. Lister R.G. Ethologically-based animal models of anxiety disorders. Pharmacol. Ther. 46:1990;321-340.
30. McGregor I.S. Using Strawberry Tree WorkbenchMac and Workbench PC software for data acquisition and control in the animal learning laboratory. Behav. Res. Meth. Instr. Comput. 28:1996;38.
31. McGregor I.S., Dastur F.N., McLellan R.A., Brown R.E. Cannabinoid modulation of rat pup ultrasonic vocalization. Eur. J. Pharmacol. 313:1996;43-49.
32. Meyer R.C., Spangler E.L., Kametani H., Ingram D.K. Age-associated memory impairment. Assessing the role of nitric oxide. Ann. N.Y. Acad. Sci. 854:1998;307-317.
33. Meyer R.C., Spangler E.L., Patel N., London E.D., Ingram D.K. Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine. Eur. J. Pharmacol. 341:1998;17-22.
34. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:1993;2002-2012.
35. Mosconi M., Chiamulera C., Recchia G. New anxiolytics in development. Int. J. Clin. Pharmacol. Res. 13:1993;331-344.
36. Nastiti K., Benton D., Brain P.F. The effects of compounds acting at the benzodiazepine receptor complex on the ultrasonic calling of mouse pups. Behav. Pharmacol. 2:1991;121-128.
37. Pögün S., Kuhar M.J. Regulation of neurotransmitter reuptake by nitric oxide. Ann. N.Y. Acad. Sci. 738:1994;305-315.
38. Prickaerts J., De Vente J., Markerink Van Ittersum M., Steinbusch H.W. Behavioral, neurochemical and neuroanatomical effects of chronic postnatal N-nitro-L-arginine methyl ester treatment in neonatal and adult rats. Neuroscience. 87:1998;181-195.
39. Quock R.M., Nguyen E. Possible involvement of nitric oxide in chlordiazepoxide-induced anxiolysis in mice. Life Sci. 51:1992;PL255-PL260.
40. Rice A.S. Topical spinal administration of a nitric oxide synthase inhibitor prevents the hyper-reflexia associated with a rat model of persistent visceral pain. Neurosci. Lett. 187:1995;111-114.
41. Salter M., Strijbos P.J., Neale S., Duffy C., Follenfant R.L., Garthwaite J. The nitric oxide-cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway. Neuroscience. 73:1996;649-655.
42. Simon E. Nitric oxide as a peripheral and central mediator in temperature regulation. Amino Acids. 14:1998;87-93.
43. Starr M.S., Starr B.S. Do NMDA receptor-mediated changes in motor behavior involve nitric oxide? Eur. J. Pharmacol. 272:1995;211-217.
44. Steiner A.A., Carnio E.C., Autunes-Rodrigues J., Branco L.G. Role of nitric oxide in systemic vasopressin-induced hypothermia. Am. J. Physiol. 275:1998;R937-R941.
45. Verrecchia C., Buisson A., Lakhmeche N., Plotkine M., Boulu R.G. Nitric oxide and cerebral ischemia. Ann. N.Y. Acad. Sci. 738:1994;341-347.
46. Vincent S.R., Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 46:1992;755-784.
47. Volke V., Koks S., Vasar E., Bourin M., Bradwejn J., Mannisto P.T. Inhibition of nitric oxide synthase caused anxiolytic-like behavior in an elevated plus-maze. NeuroReport. 6:1995;1413-1416.
48. Volke V., Soosaar A., Koks S., Bourin M., Mannisto P.T., Vasar E. 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology. 131:1997;399-405.
49. Winslow J.T., Insel T.R. Serotonergic and catecholaminergic reuptake inhibitors have opposite effects on the ultrasonic isolation calls of rat pups. Neuropsychopharmacology. 3:1990;51-59.
50. Winslow J.T., Insel T.R. The infant rat separation paradigm: a novel test for novel anxiolytics. Trends Pharmacol. Sci. 12:1991;402-404.
51. Winslow J.T., Insel T.R., Trullas R., Skolnick P. Rat pup isolation calls are reduced by functional antagonists of the NMDA receptor complex. Eur. J. Pharmacol. 190:1990;11-21.
52. Zhang J., Snyder S.H. Nitric oxide in the nervous system. Annu. Rev. Pharmacol. Toxicol. 35:1995;213-233.